ANI Pharmaceuticals's total assets for Q1 2025 were $1.29B, an increase of 0.68% from the previous quarter. ANIP total liabilities were $848.96M for the fiscal quarter, a -0.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.